KA
AGN

Kintegral Advisory’s Allergan plc AGN Stock Holding History

Kintegral Advisory’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-3,911
Closed -$693K – 269
2020
Q1 		$693K Buy
3,911
+438
+13% +$82.5K 0.14% 138
2019
Q4 		$664K Hold
3,473
– – 0.12% 161
2019
Q3 		$584K Hold
3,473
– – 0.12% 169
2019
Q2 		$581K Hold
3,473
– – 0.12% 170
2019
Q1 		$508K Buy
3,473
+1,852
+114% +$269K 0.11% 183
2018
Q4 		$217K Buy
+1,621
New +$266K 0.06% 214

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Kintegral Advisory's AGN Position: Q2 2020 in Review

Kintegral Advisory sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 3,911 shares — an estimated $693K sold.

Kintegral Advisory first reported a position in AGN in Q4 2018 and held it in 6 quarters. The position peaked at $693K in Q1 2020. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Kintegral Advisory reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Kintegral Advisory sold 3,911 Allergan plc shares in Q2 2020, an estimated $693K.
  • Kintegral Advisory first reported a position in Allergan plc in Q4 2018 and held it in 6 quarters.
  • Kintegral Advisory's Allergan plc position peaked at $693K in Q1 2020.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Kintegral Advisory's 13F filing for Q2 2020, filed 12 Aug 2020.